Form 4: PROCEPT BioRobotics Director Receives Stock Grant
Insider Transaction (Form 4)
Michael Mack, a Director of PROCEPT BioRobotics Corp, reported multiple transactions in common stock on October 2, 2026.
Summary
- Grant/award: acquired 7,727 Common Stock on October 2, 2026; holds 7,727 after (Direct).
- Grant/award: acquired 12,191 Stock Option (Right to Buy) on October 2, 2026; holds 12,191 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Michael Mack — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Grant/award | Common Stock | 7,727 | — | — | 7,727 |
| 2026-10-02 | Grant/award | Stock Option (Right to Buy) | 12,191 | — | — | 12,191 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Grant/award (7,727 shares) |
| 2026-10-02 | Grant/award (12,191 shares) |
Keywords
insider transaction, Form 4, PRCT, PROCEPT BioRobotics Corp, neutral, Michael Mack
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.